Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up

Go back to Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
(NASDAQ: CLOV) Delayed: 4.29 +0.03 (0.70%)
Previous Close $4.26    52 Week High
Open $4.23    52 Week Low
Day High $4.34    P/E N/A 
Day Low $4.12    EPS
Volume 3,047,189